Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IMCD NVIMCDY -1.90%93 Cash-to-Debt is 0.14 as of Jun. 2026, which is 22% below its 10-year median of 0.18. GuruFocus rates IMCDY with a GF Score™ of 93/100 and a GF Value™ of $73.71 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 1,590 Chemicals companies, IMCD NV ranks worse than 80% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. IMCD NV's cash to debt ratio for the quarter that ended in Jun. 2026 was 0.14.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, IMCD NVcouldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.
The historical rank and industry rank for IMCD NV's Cash-to-Debt or its related term are showing as below:
IMCDY'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.14 Med: 0.18 Max: 0.43
Current: 0.17
During the past 13 years, IMCD NV's highest Cash to Debt Ratio was 0.43. The lowest was 0.14. And the median was 0.18.
IMCDY's Cash-to-Debt is ranked worse than 80% of 1590
companies
in the Chemicals industry
Industry Median: 0.67
vs IMCDY: 0.17
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
IMCD NV Cash-to-Debt Related Terms
IMCD NV Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for IMCD NV's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Specialty Chemicals subindustry, IMCD NV's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IMCD NV Cash-to-Debt vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, IMCD NV's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where IMCD NV's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IMCD NV (IMCDY) has a Cash-to-Debt of 0.14 as of Jun. 2026. This is 22% below median its historical median of 0.18. Over the past decade, IMCD NV's Cash-to-Debt has ranged from 0.14 to 0.43. According to the industry distribution chart, IMCD NV ranks #1272 out of 1590 companies in the Chemicals industry, placing it in the top 80%.
Is IMCD NV's Cash-to-Debt too high?
IMCD NV's current Cash-to-Debt of 0.14 is 22% below median its 10-year median of 0.18. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 0.43. The Chemicals industry median Cash-to-Debt is 0.67. IMCD NV's value of 0.14 is 79.1% below this industry median. Based on the distribution chart, IMCD NV ranks #1272 out of 1590 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, IMCD NV has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IMCD NV's Cash-to-Debt compare to LIN and SHW?
According to the Chemicals industry distribution chart, IMCD NV ranks #1272 out of 1590 companies for Cash-to-Debt. This places IMCD NV in the lower half of its industry. The industry median Cash-to-Debt is 0.67. IMCD NV's value of 0.14 is 79.1% below this benchmark. Historically, IMCD NV's own Cash-to-Debt has ranged from 0.14 to 0.43 over the past decade. While the company's 10-year median is 0.18 vs. the industry median of 0.67, IMCD NV has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Chemicals company?
The median Cash-to-Debt among Chemicals companies is 0.67, based on 1,590 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IMCD NV's current Cash-to-Debt of 0.14 is 79.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median Cash-to-Debt is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IMCD NV's current Cash-to-Debt is 0.14, which is 22% below median its own 10-year median of 0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMCD NV stock overvalued right now?
Based on GuruFocus' analysis, IMCD NV (IMCDY) is currently considered Modestly Undervalued. The stock's GF Value™ is $73.71, compared to a current price of $53.56 — trading 27.3% below its estimated fair value. The current Cash-to-Debt is 0.14, which is 22% below median its 10-year median of 0.18 and 79.1% below the Chemicals industry median of 0.67. IMCD NV's overall GF Score™ is 93/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For IMCD NV (IMCDY), the current Cash-to-Debt is 0.14 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IMCD NV (IMCDY) Overvalued in 2026?
Based on GuruFocus' analysis, IMCD NV stock appears to be undervalued.
The current stock price of $53.56 is trading 27.3% below its estimated GF Value™ of $73.71.
GuruFocus considers IMCD NV to be Modestly Undervalued.
Key valuation signals for IMCDY:
Cash-to-Debt: 0.14 (22% below median its 10-year median of 0.18)
GF Value™: $73.71 vs. price of $53.56 (27.3% below fair value)
Industry Position: 79.1% below the Chemicals median (#1272 of 1590)
No single metric tells the full story. See the IMCDY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IMCD NV is a distributor and formulator of specialty chemicals and ingredients for industrial and life-science markets. The company's product portfolio consists of two categories: Life Science, which consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care I&I, and the Industrial segment, which contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment, which includes Europe, Turkiye, Israel, Egypt, the United Arab Emirates, Saudi Arabia and Africa.
93GF Score
Get the complete analysis for IMCDY
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IMCDY has been successfully added to your 
